Kunal Joon*

Noida International Institute of Medical Sciences, Haryana, India

*Corresponding Author: Kunal Joon, Noida International Institute of Medical Sciences, Haryana, India.

Received: February 26, 2024; Published: March 02, 2024

Abstract

Glaucoma is characterised by a progressive degeneration of optic nerve with Corresponding visual loss and ultimately blindness if left untreated.

Keywords: Glaucoma; Degeneration; Neuro Ophthalmology; Blindness; Visual Loss; Drug Statistics

References

1. https://pubmed.ncbi.nlm.nih.gov/26182236
2. https://pubmed.ncbi.nlm.nih.gov/26111782
3. https://pubmed.ncbi.nlm.nih.gov/19574692/
4. https://pubmed.ncbi.nlm.nih.gov/18170651/
5. https://pubmed.ncbi.nlm.nih.gov/22346129/
6. https://pubmed.ncbi.nlm.nih.gov/23556149/
7. https://pubmed.ncbi.nlm.nih.gov/27014388
8. https://pubmed.ncbi.nlm.nih.gov/575877/
9. https://pubmed.ncbi.nlm.nih.gov/33519186
10. https://pubmed.ncbi.nlm.nih.gov/30089089/

Citation

Citation: Kunal Joon. “Drug Development in Case of Glaucoma".Acta Scientific Ophthalmology 7.4 (2024): 01-02.

Copyright

Copyright: © 2024 Kunal Joon. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.